BSCL2 and fatty liver disease: Together, these reveal that hepatic deficiency of seipin does not appear to be responsible for significant increases in hepatocyte lipid content or the severe hepatic steatosis that is observed in global Bscl2 knockout mouse models or patients suffering from CGL2.